Organon & Co. (OGN)
7.175
-0.18
(-2.51%)
USD |
NYSE |
Dec 12, 16:00
7.18
0.00 (0.00%)
After-Hours: 17:08
Organon Total Assets (Quarterly): 13.55B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Merck & Co., Inc. | 129.55B |
| Amgen, Inc. | 90.14B |
| Regeneron Pharmaceuticals, Inc. | 40.17B |
| Rockwell Medical, Inc. | 57.49M |
| United Therapeutics Corp. | 7.351B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 12.65B |
| Shareholders Equity (Quarterly) | 906.00M |
| Debt to Equity Ratio | 9.744 |
| Current Ratio | 1.754 |
| Net Debt Paydown Yield | -1.24% |